Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-09-13

Clinical Trial Update: Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated a combination of Momordica Charantia extract with primaquine for the treatment of uncomplicated Plasmodium falciparum and Pla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Momordica Charantia extract (Momordica Charantia extract)
  • Primaquine (primaquine)

Snippet

Sponsor: Syamsudin Abdillah,Ph.D, Pharm D | Conditions: Malaria,Falciparum, Malaria, Vivax | Phase 2 | Status: COMPLETED